Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD) (NCT07622134) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effectiveness of Health Literacy Program for Polypharmacy Patients (HLP-CKD)
Thailand104 participantsStarted 2026-06-15
Plain-language summary
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.
Who can participate
Age range
55 Years – 74 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 55-74 years diagnosed with non-communicable diseases.
* Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
* Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
* Able to communicate, read, and write in Thai.
* Willing to participate in the 8-week program and follow-up assessments.
Exclusion Criteria:
* Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5.
* Having severe cognitive impairment or psychiatric disorders that prevent participation.
* Having severe complications or being in an unstable clinical condition.
* Planning to move out of the study area during the 12-week study period.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Health Literacy Levels
Timeframe: Baseline, 8 weeks (immediately after intervention), and 12 weeks (follow-up).